Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samples.

Area of Science:

• Immunology
• Cellular immunology
• Flow cytometry

Background:

• Accurate enumeration of antigen-specific T cells is crucial for assessing immune responses, monitoring cancer vaccines, and diagnosing autoimmune diseases.
• Traditional methods like ELISpot and intracellular cytokine staining are labor-intensive and time-consuming.
• Novel flow cytometry techniques using TCR-specific multimers offer faster and more precise T cell quantification.

Purpose of the Study:

• To evaluate the performance of a Dextramer-based assay for enumerating cytomegalovirus (CMV) antigen-specific T cells (CASTs).
• To assess the sensitivity, specificity, robustness, and reproducibility of the Dextramer assay.
• To compare Dextramer assay results with Tetramer data in transplant recipients.

Main Methods:

• Assessed assay sensitivity (median=0.4; range=0.1-1.4 CASTs μl(-1)) and specificity (100%) using Dextramer reagents.
• Evaluated assay robustness with diverse leukocyte sources and reproducibility across laboratories and instruments.
• Correlated Dextramer results with Tetramer data in 95 peripheral blood samples from 62 transplant recipients.

Main Results:

• The Dextramer assay demonstrated high sensitivity and 100% specificity for enumerating CASTs.
• Robustness and reproducibility were confirmed across various conditions and settings.
• CAST levels measured by Dextramers strongly correlated with Tetramer measurements (R²=0.9042) in transplant recipients.

Conclusions:

• Dextramer reagents provide a sensitive, specific, and reproducible method for enumerating CMV antigen-specific T cells.
• This assay is a valuable tool for clinical and research applications requiring rapid and accurate T cell quantification.
• The Dextramer assay offers a reliable alternative to existing methods for immune monitoring, particularly in transplant settings.